Drug Interactions between Breztri Aerosphere and physostigmine

Using PHYSostigmine together with glycopyrrolate may decrease the benefits of PHYSostigmine in the treatment of dementia. PHYSostigmine may also counteract the benefit of glycopyrrolate. Glycopyrrolate should generally be avoided in patients with Alzheimer's disease or other cognitive problems. Glycopyrrolate may also adversely affect elderly patients by producing symptoms ranging from mild thinking impairment to delirium. It is important that you tell your healthcare provider about all other medications that you are using including vitamins and herbs. Do not stop using your medications without first talking to your doctor.

Using budesonide together with PHYSostigmine may result in severe muscle weakness in patients with myasthenia gravis. If you have been receiving treatment with PHYSostigmine, you may experience increased muscle weakness when budesonide is first initiated. Improvement in muscular function may occur gradually. Talk to your doctor if you have any questions or concerns. Your doctor may discontinue PHYSostigmine at least one day before you start taking budesonide. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Information for this minor interaction is available on the professional version.